Articles by tag: hiv-treatment

EMA accepted the application for Dovato for children with HIV

EMA validated the application for the use of Dovato in children from 3 months with HIV. Learn how this will change pediatric therapy and strengthen ViiV's position. Read the detailed analysis.

Islatravir: New HIV Pill Approved by FDA

FDA approved Idvynso (doravirine/islatravir) — the first two-drug regimen without INSTI and tenofovir. Learn why this is a new standard of therapy for aging HIV patients. Read details.

Pediatric Dovato: EMA Approves Application for HIV Therapy

EMA validated the application for pediatric Dovato (dolutegravir/lamivudine) for children from 2 years old. Learn how two-drug therapy is changing HIV treatment standards.

Smart drugs for cancer and HIV: Russian development

Russian scientists are creating 'smart drugs' based on nucleic acids for targeted attack on cancer and HIV. Learn about the platform of the future and personalized medicine.